Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

281 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A

NCT00157040

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children´s Hospital Los Angeles Los Angeles, California, United States
  • Emory University, Department of Pediatrics Atlanta, Georgia, United States
  • Children´s Memorial Hospital Chicago, Illinois, United States
  • Comprehensive Bleeding Disorders Center Peoria, Illinois, United States
View Trial Details
Completed

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

NCT02093741

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • CHRU Pellegrin, Hématologie - CRTH Bordeaux, France
  • Centre Hospitalier Générale, CTH Chambéry, France
  • CRTH Laboratoire d'Hématologie CHRU - Hôpital du Bocage Dijon, France
  • American Memorial Hospital, Service de Pédiatrie Reims, France
View all 17 locations
View Trial Details
Completed

GAS-Hem Feasibility Study

NCT02674997

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • St. Paul's Hospital Vancouver, British Columbia, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details
Completed

ADVATE Post Authorization Safety Surveillance

NCT00214734

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • PHOENIX CHILDRENS Hospital Phoenix, Arizona, United States
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • City of Hope National Medical Center Duarte, California, United States
  • LONG BEACH MEMORIAL MED Center Long Beach, California, United States
View all 37 locations
View Trial Details
Completed

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

NCT02634723

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Institute of Hematology and Oncology, Harbin The First Hospital Harbin, Heilongjiang, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
  • Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology Wuhan, Hubei, China
  • Nanjing Children's Hospital Affiliated to Nanjing Medical University Nanjing, Jiangsu, China
View Trial Details
Completed

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

NCT02190149

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • Rady Childrens Hospital San Diego, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

NCT02035605

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Clinical Trial Site Pittsburgh, Pennsylvania, United States
  • Clinical Trial Site Plovdiv, Bulgaria
  • Clinical Trial Site Sofia, Bulgaria
  • Clinical Trial Site Varna, Bulgaria
View all 14 locations
View Trial Details

Related conditions